Evidence map›Paper›PMID 42811523›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Electronic-State Programming of Ultrasmall CeO

Bo Yuan, Xinyu Wu, Yin-Song Liao, Chao Zhao, Zhanping Xiao, Wanqing Dai, Jyh-Pin Chou, Wenchao Peng, Jian Lin Chen, Pi-Tai Chou and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bo Yuan *Department of Chemistry, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Xinyu Wu *Department of Chemistry, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Yin-Song Liao *Graduate School of Advanced Technology, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0009-0004-8792-5627
Chao ZhaoDepartment of Chemistry, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0002-4457-5039
Zhanping XiaoDepartment of Chemistry, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Wanqing DaiDepartment of Applied Science, School of Science and Technology, Hong Kong Metropolitan University, Hong Kong, Hong Kong SAR, China.
Jyh-Pin ChouGraduate School of Advanced Technology, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-8336-6793
Wenchao PengSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0002-1515-8287
Jian Lin ChenDepartment of Applied Science, School of Science and Technology, Hong Kong Metropolitan University, Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0001-6661-1734
Pi-Tai ChouDepartment of Chemistry, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-8925-7747
Yung-Kang PengDepartment of Chemistry, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0001-9590-6902

Funding

Hong Kong Research Grants Council C5081-21EHong Kong Research Grants Council CityU 11300524Hong Kong Research Grants Council CityU 11301625National Applied Research LaboratoriesNational Center for High-performance Computing
6 · The paper itself

Abstract

Antibiotic resistance, driven by antibiotic-resistant bacteria (ARB) and genes (ARGs) in aquatic systems, is an escalating threat. Conventional advanced oxidation processes (AOPs) based on OH radicals are limited by rapid radical scavenging.

Indexed as

antibiotic resistancebio‐inspired 1O2 productionelectronic state optimizationscalable productionultrasmall CeO2 catalysts

Identifiers

PMID42811523
PMCPMC13624328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.